Cargando…
Hyper-Interleukin-6 Protects Against Renal Ischemic-Reperfusion Injury—A Mouse Model
Background: Most of the ischemia-reperfusion injury (IR-I) occurs during reperfusion and is mediated by the immune system. In this study we determined whether immunomodulation with hyper-Interleukin-6 (a recombinant designer cytokine composed of interleukin-6 linked to its soluble receptor) is prote...
Autores principales: | Zuaiter, Mohammad, Axelrod, Jonathan H., Pizov, Galina, Gofrit, Ofer N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155529/ https://www.ncbi.nlm.nih.gov/pubmed/34055865 http://dx.doi.org/10.3389/fsurg.2021.605675 |
Ejemplares similares
-
Expression of the H19 Oncofetal Gene in Premalignant Lesions of Cervical Cancer: A Potential Targeting Approach for Development of Nonsurgical Treatment of High-Risk Lesions
por: Feigenberg, Tomer, et al.
Publicado: (2013) -
Protective effect of renal ischemic postconditioning in renal ischemic-reperfusion injury
por: Tian, Ying, et al.
Publicado: (2020) -
False Positive Findings of [(18)F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels
por: Orevi, Marina, et al.
Publicado: (2022) -
Transurethral Prostatectomy Before or After External Beam Radiotherapy: Complications and Reoperation Rates
por: Molineros, Gabriel, et al.
Publicado: (2021) -
Gross Hematuria in Patients with Prostate Cancer: Etiology and Management
por: Gofrit, Ofer N., et al.
Publicado: (2013)